August 2017

Marine-Derived Drug Anchors Chemo Regimen in Phase III Lung Cancer Trial

August 09, 2017

Clinical Trials in Progress

The phase III ATLANTIS trial is testing the investigational synthetic analogue lurbinectedin in combination with doxoubicin for use in patients with recurrent small cel lung cancer (SCLC).

Sunscreens: What You Need to Know

August 03, 2017

Nurse Navigators

Confusion about sunscreen options and ingredients can lead to inadequate sun protection and increased skin cancer risk. The Environmental Working Group has resources to help.

Fast Facts for the Front Line: Central Line-Associated Bloodstream Infection

August 02, 2017

Fast Facts for the Frontline

Preventing central line–associated bloodstream infections is a top priority for healthcare practitioners, and following basic safety protocols, such as handwashing and line flushing, is essential to the effort.